We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+23.26%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$248M
AUM Growth
+$55.4M
Cap. Flow
+$21.4M
Cap. Flow %
8.61%
Top 10 Hldgs %
45.77%
Holding
38
New
5
Increased
25
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
WCC
WESCO International
WCC
+$7.74M
2
BIDU icon
Baidu
BIDU
+$4.02M
3
KEX icon
Kirby Corp
KEX
+$3.57M
4
SLB icon
SLB Ltd
SLB
+$3.39M
5
FNV icon
Franco-Nevada
FNV
+$2.34M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$3.89M
2
GMLP
Golar LNG Partners LP
GMLP
+$91K
3
MCHP icon
Microchip Technology
MCHP
+$49.1K
4
PFE icon
Pfizer
PFE
+$48.1K
5
RUSHB icon
Rush Enterprises Class B
RUSHB
+$6.35K

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Technology 18.12%
3 Industrials 16.51%
4 Consumer Discretionary 14.65%
5 Financials 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.4B
$4.44M 1.79%
18,147
+94
+0.5% +$24.2K
WAB icon
27
Wabtec
WAB
$44.5B
$4.02M 1.62%
54,964
+771
+1% +$52.7K
SLB icon
28
SLB Ltd
SLB
$70.3B
$3.92M 1.58%
+179,410
New +$3.39M
GILD icon
29
Gilead Sciences
GILD
$167B
$2.96M 1.19%
50,803
+643
+1% +$38.8K
FNV icon
30
Franco-Nevada
FNV
$38.7B
$2.18M 0.88%
+17,368
New +$2.34M
RGLD icon
31
Royal Gold
RGLD
$16.1B
$2.12M 0.85%
+19,924
New +$2.3M
PFE icon
32
Pfizer
PFE
$143B
$874K 0.35%
23,739
-1,311
-5% -$48.1K
MS icon
33
Morgan Stanley
MS
$339B
$740K 0.3%
10,805
– –
CTSH icon
34
Cognizant
CTSH
$21.2B
$737K 0.3%
8,998
+992
+12% +$75.5K
EPD icon
35
Enterprise Products Partners
EPD
$82.6B
$487K 0.2%
24,855
– –
RUSHB icon
36
Rush Enterprises Class B
RUSHB
$5.89B
$254K 0.1%
10,041
-275
-3% -$6.35K
BMY.RT
37
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$48K 0.02%
69,403
-593
-0.8% -$1.26K
GMLP
38
DELISTED
Golar LNG Partners LP
GMLP
– –
-44,960
Closed -$91K
1
2

Similar funds

AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM
MW
Marks Wealth Annapolis, Maryland $380M AUM 40.02% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
RWA
Rooted Wealth Advisors Bourbonnais, Illinois $379M AUM 13.75% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $379M AUM 19.59% 1-Year Est. Return
BP
BWM Planning The Woodlands, Texas $379M AUM 21.72% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return

Muhlenkamp & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Muhlenkamp & Co held 38 positions worth $248M, up 29% from $193M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Muhlenkamp & Co deployed $21.4M of net new capital in Q4 2020, opening 5 new positions and adding to 25 existing holdings. Its largest new stake was WESCO International: 130,683 shares worth $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $3.89M trimmed.

  • Muhlenkamp & Co's largest Q4 2020 buy was WESCO International: 130,683 shares worth $10.3M.
  • Muhlenkamp & Co added most to Kirby Corp in Q4 2020, an estimated $3.57M increase.
  • Muhlenkamp & Co's biggest Q4 2020 reduction was SPDR Gold Trust, cutting an estimated $3.89M.
  • Muhlenkamp & Co fully exited Golar LNG Partners LP in Q4 2020, selling an estimated $91K.
  • Muhlenkamp & Co's ten largest holdings make up 46% of its $248M portfolio in Q4 2020.
  • Muhlenkamp & Co opened 5 new positions and closed 1 in Q4 2020.
  • Muhlenkamp & Co's portfolio value rose 29% quarter-over-quarter to $248M.

Based on Muhlenkamp & Co's 13F filing for Q4 2020, filed 11 Feb 2021.